Stock Research for TGTX

TGTX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

TGTX Stock Chart & Research Data

The TGTX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the TGTX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


TGTX Due diligence Resources & Stock Charts

The TGTX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View TGTX Detailed Price Forecast - CNN Money CNN View TGTX Detailed Summary - Google Finance
Yahoo View TGTX Detailed Summary - Yahoo! Finance Zacks View TGTX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View TGTX Trends & Analysis - Trade-Ideas Barrons View TGTX Major Holders - Barrons
NASDAQ View TGTX Call Transcripts - NASDAQ Seeking View TGTX Breaking News & Analysis - Seeking Alpha
Spotlight View TGTX Annual Report - CompanySpotlight.com OTC Report View TGTX OTC Short Report - OTCShortReport.com
TradeKing View TGTX Fundamentals - TradeKing Charts View TGTX SEC Filings - Bar Chart
WSJ View Historical Prices for TGTX - The WSJ Morningstar View Performance/Total Return for TGTX - Morningstar
MarketWatch View the Analyst Estimates for TGTX - MarketWatch CNBC View the Earnings History for TGTX - CNBC
StockMarketWatch View the TGTX Earnings - StockMarketWatch MacroAxis View TGTX Buy or Sell Recommendations - MacroAxis
Bullish View the TGTX Bullish Patterns - American Bulls Short Pains View TGTX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View TGTX Stock Mentions - StockTwits PennyStocks View TGTX Stock Mentions - PennyStockTweets
Twitter View TGTX Stock Mentions - Twitter Invest Hub View TGTX Investment Forum News - Investor Hub
Yahoo View TGTX Stock Mentions - Yahoo! Message Board Seeking Alpha View TGTX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for TGTX - SECform4.com Insider Cow View Insider Transactions for TGTX - Insider Cow
CNBC View TGTX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for TGTX - OTC Markets
Yahoo View Insider Transactions for TGTX - Yahoo! Finance NASDAQ View Institutional Holdings for TGTX - NASDAQ


Stock Charts

FinViz View TGTX Stock Insight & Charts - FinViz.com StockCharts View TGTX Investment Charts - StockCharts.com
BarChart View TGTX Stock Overview & Charts - BarChart Trading View View TGTX User Generated Charts - Trading View




Latest Financial News for TGTX


SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TG Therapeutics, Inc. - TGTX
Posted on Wednesday December 12, 2018

NEW YORK, NY / ACCESSWIRE / December 12, 2018 / Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. (''TG'' or the ''Company'') (TGTX) Investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. On September 25, 2018, TG announced that it would not be releasing data from the UNITY-CLL Phase 3 study of the Company's leukemia treatment TG-1101 (ublituximab) and that the study had failed to meet the overall response rate (''ORR'') stated goal.In a press release, TG announced that the trial's Data Safety Monitoring Board had met to review ongoing data from the UNITY-CLL study and advised the Company that the interim analysis of the ORR could not be conducted at that time because the data was not sufficiently mature to conduct the analysis.


3 Beaten-Down Biotech Stocks That Could Bounce Back in 2019
Posted on Wednesday December 12, 2018

A new year and reasons to remain hopeful for these three biotechs are around the corner.


Recent Analysis Shows Verizon Communications, MGM Resorts International, Exelon, Axon Enterprise, M.D.C., and TG Therapeutics Market Influences — Renewed Outlook, Key Drivers of Growth
Posted on Wednesday December 12, 2018

NEW YORK, Dec. 12, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.


Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Trevena, Inc.
Posted on Wednesday December 05, 2018

Law Offices of Howard G. Smith reminds investors of the December 10, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ: TGTX) securities between May 2, 2018 and October 8, 2018, inclusive (the “Class Period”). Trevena investors have until December 10, 2018 to file a lead plaintiff motion. Investors suffering losses on their Trevena investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.